Event Date/Time: Jan 29, 2011
End Date/Time: Jan 29, 2011
This symposium will concentrate on key results presented at recent major international oncology meetings, such as the San Antonio Breast Cancer Symposium, with the potential to change standards of practice in breast oncology. The symposium will present these data in a clinical context in order to facilitate integration of the information into practice in an effort to improve treatment selection and patient care. Controversial and emerging topics, including optimal adjuvant and neoadjuvant therapies, the evolving role of biologic agents, current and future uses of breast cancer genotyping, and the optimal treatment of metastatic breast cancer, will be addressed. The symposium will also focus on new agents in development that will have an impact on the natural history of breast cancer. Case presentations and panel discussions will allow participants to discuss current controversies in the treatment of breast cancer with the faculty.